Introduction
The EbGlyss launch event aims to introduce healthcare professionals to a novel therapeutic option in the treatment of atopic dermatitis . This activity will provide a comprehensive overview of the clinical profile of EbGlyss (lebrikizumab), including its mechanism of action, efficacy and safety data, patient selection criteria, and its role in current treatment paradigms. The launch will also highlight unmet needs in dermatological care and how EbGlyss addresses them, fostering evidence-based adoption and optimized patient outcomes.
Objectives
•To educate HCPs on the scientific rationale behind IL-13 blockade and how it translates to clinical efficacy in atopic dermatitis.
•To familiarize clinicians with the pivotal clinical trials and real-world data supporting the use of EbGlyss.
•To provide clarity on patient selection and treatment optimization with EbGlyss.
•To encourage dialogue and knowledge exchange among experts regarding best practices in managing moderate-to-severe atopic dermatitis.
•To support the integration of EbGlyss into current treatment algorithms and national/international guidelines where applicable.
This Course For :
Physician
( Allergy & Immunology , Dermatology , Internal Medicine )
Resident / Fellow
( Allergy & Immunology , Dermatology , Internal Medicine )
Pharmacy
Speaker
Brig.Gen. Bander Al Harbi
Director of Pharmaceutical Services, Prince Sultan Military Medical City
Professor Richard G. Langley
Dr Langley is Professor and Director of Research in the Division of Dermatology, Department of Medicine, Dalhousie University, Canada, and was President of the Canadian Dermatology Association in 2014.
Dr Langley has authored over 300 articles, book chapters, and other publications and he is a regular reviewer for several medical and dermatology journals. He is a principal investigator and has conducted over 250 Phase 1–3 studies involving most of the biologic agents in psoriasis and new immunotherapies in atopic dermatitis.
Associate Professor Raj Jitendra Chovatiya
Raj Chovatiya, MD, PhD, MSCI, FAAD is Clinical Associate Professor of Medicine at Rosalind Franklin
University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and
Immunology Research in Chicago, Illinois. His clinical and research focus includes the intersection of
cutaneous immunology and inflammatory disease. He received his MD and PhD in immunology from Yale
and completed his residency, postdoctoral research fellowship, and MS in Clinical Investigation at
Northwestern University where he also served as Chief Resident. Dr. Chovatiya has a particular interest
in optimizing patient-centered care, understanding chronic disease burden especially in understudied
inflammatory diseases, exploring health and social disparities, and improving care across diverse skin
types. He has published numerous abstracts and manuscripts and has been nationally and internationally
recognized for his contributions as a clinician, educator, researcher, and leader.
Dr Mohamad Ibrahim Fatani
Dr. Fatani has extensive experience in dermatology, having worked at various hospitals across Saudi Arabia. He has been a consultant at HGH since November 2000 and has held several administrative roles, including Director of the virtual clinic and Head of the Dermatology Department. He is also a board member of the Saudi Society of Dermatology and Dermatologic Surgery
Dr. Ru'aa Alharithy. MD, MScCH, FRCPC, FAAD
Graduate of University of Toronto Dermatology Residency Rrogram 2010. Master of Science in Community Health, Health Professions Teacher Education Dalla Lana Public health school, University of Toronto. Canada Fellow of the Royal College of Physicians and Surgeons of Canada and the American Academy of Dermatology. former director of dermatology residency program of the central region of Saudi Arabia and member of the scientific council 2017-2020. Currently, Dermatology Consultant at Security Forces Hospital, Riyadh, member of multiple scientific committees of national and international conferences and editor at multiple medical journals. Lectures nationally and internationally.
Issam R. Hamadah
Consultant Dermatologist, KFSH & RC
Clinical Professor, Alfaisal University
Afaf Al-Alsheikh, MD, FAAD
Consultant Dermatologist
Head division of Dermatology, Department of Medicine
King Abdulaziz Medical City, Riyadh
Assistant Professor, King Saud Bin Abdulaziz University for Health Sciences
Dr.Yousef Binamer
MD,EMBA,FRCPC,DABD,FAAD
Chairman development of dermatology at King Faisal Specialist Hospital and Research Centre,Riyadh
Dr. Abdullah Faisal Albadri
Consultant & Head of dermatology department at King Fahad General Hospital Jeddah, KSA. Dermatology Service Lead at Ministry of Health -Jeddah. German Board & Fellowship in Allergy, Vivantes Hospital, Charite University
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
25 Apr 2025 To 25 Apr 2025 -
05:00 PM To 08:00 PM 
Certificate Available 
Online
- 9
Add to Calendar
04/25/2025 05:00 PM
04/25/2025 08:00 PM
Asia/ Riyadh
Ebglyss (Lebrikizumab) Launch KSA
Ebglyss (Lebrikizumab) Launch KSA
https://medicalacademy.org/portal/event/view/2370
